Cellular Versus Acellular Matrix Products for Diabetic Foot Ulcer Treatment: The Dermagraft and Oasis Longitudinal Comparative Efficacy Study (DOLCE)—A Randomized Clinical Trial
No difference in efficacy was found between SOC, ACM, and CM, suggesting that SOC can reduce the economic burden of diabetic foot ulcer treatment.
Authors
- R. Rivkah Isseroff (ORCID: https://orcid.org/0000-0001-7813-0858)
- Ramanjot Kaur
- Nuen Tsang Yang (ORCID: https://orcid.org/0000-0002-3074-5930)
- David M. Rocke (ORCID: https://orcid.org/0000-0002-3958-7318)
- Catherine N. Tchanque‐Fossuo (ORCID: https://orcid.org/0000-0002-5995-6985)
- Hadar Lev‐Tov (ORCID: https://orcid.org/0000-0001-6223-7001)
- Kaitlyn West
- Harrison Shawa (ORCID: https://orcid.org/0000-0001-8437-4445)
- Chin‐Shang Li (ORCID: https://orcid.org/0000-0002-0054-4476)
- Mirabel Dafinone (ORCID: https://orcid.org/0009-0000-6273-7954)
- Rawlings E. Lyle (ORCID: https://orcid.org/0000-0002-0525-2392)
- Sara Dahle
- Pauline Lim
Institutions
- University of Nevada, Las Vegas (US)
- University of Nevada, Reno (US)
- VA Northern California Health Care System (US)
- University of California, Davis (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-04-29
- DOI
- https://doi.org/10.2337/dc24-1233
- Citations
- 2
- Primary Topic
- Wound Healing and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.05